Today: 9 June 2026
Browse Category

SHA:688256 30 September 2025 - 1 March 2026

Shanghai Stock Exchange week ahead: Two Sessions and PMI loom after Shanghai Composite ends Friday higher

Shanghai Stock Exchange week ahead: Two Sessions and PMI loom after Shanghai Composite ends Friday higher

Shanghai Composite closed up 0.39% at 4,162.88 on Friday, while the CSI 300 fell 0.34% and traders await key policy signals from the upcoming “Two Sessions” meetings starting March 4. The Politburo called for more proactive fiscal measures as investors look for growth targets and budget details. Cambricon reported 2025 net profit of 2.06 billion yuan, with revenue up 450%. February PMI data is due March 4.
1 March 2026
··
Cambricon Class A stock price dips again: what to watch next for China AI chip name 688256

Cambricon Class A stock price dips again: what to watch next for China AI chip name 688256

Cambricon Technologies shares closed at 1,036.99 yuan in Shanghai on Friday, down 2.02%, with volume at about 8 million shares. The stock has fallen roughly 16.5% since Feb. 2 after sharp declines earlier in the week. Investors await the company’s next earnings report, due March 13, for confirmation of its forecasted profit turnaround. Cambricon is valued at about 437.28 billion yuan.
8 February 2026
·
Cambricon Technologies stock price in focus after 2025 profit forecast, “U” tag in play

Cambricon Technologies stock price in focus after 2025 profit forecast, “U” tag in play

Cambricon Technologies expects its first annual profit since listing, forecasting 2025 net income of 1.85–2.15 billion yuan on revenue of 6–7 billion yuan, citing AI computing demand. Shares closed up 0.6% Friday in Shanghai. The company’s “U” suffix may be dropped if audited results in March confirm the turnaround. Cambricon posted a 2024 net loss of 452 million yuan on 1.17 billion yuan revenue.
1 February 2026
··
Cambricon stock (688256) on watch after fund filings reshuffle China AI chip bets

Cambricon stock (688256) on watch after fund filings reshuffle China AI chip bets

Cambricon Technologies’ Class A shares closed down 1.33% at 1,334.99 yuan Friday, despite ranking among the top 10 most-held stocks by mainland mutual funds at year-end. Trading volume reached 6.35 million shares. Guoyuan Securities will begin market-making in Cambricon under STAR Market rules this week. Enflame, another domestic AI chipmaker, received approval for a STAR Market IPO targeting 6 billion yuan.
25 January 2026
·
Cambricon stock: China’s leverage curb puts AI-chip favorite in focus before Shanghai open

Cambricon stock: China’s leverage curb puts AI-chip favorite in focus before Shanghai open

China’s stock exchanges will raise the minimum margin requirement for new leveraged trades to 100% from 80% starting Monday. Cambricon Technologies Class A shares closed at 1,424.05 yuan Friday, up 0.6%, ahead of the rule change. Traders are watching for forced selling in high-momentum tech stocks as the new rules take effect. Existing margin contracts remain under previous requirements.
19 January 2026
··
China’s DeepSeek Unveils AI Model Halving Costs by 50% – The ‘Sparse Attention’ Revolution

China’s DeepSeek Unveils AI Model Halving Costs by 50% – The ‘Sparse Attention’ Revolution

DeepSeek on Sept. 29 released DeepSeek-V3.2-Exp, an open-source language model using a new “sparse attention” method to cut API inference costs by about 50% for long texts. The model is available under an MIT license and supports Chinese AI chips. Early tests show token costs dropping from $0.07 to $0.028 per million, though performance still trails top models like GPT-5.
30 September 2025
··

Stock Market Today

  • Soybeans Trade Mixed as Export Sales and Crop Reports Influence Prices
    June 9, 2026, 10:52 AM EDT. Soybean futures exhibited mixed trading Tuesday morning after a decline Monday, with July contracts down 5 3/4 cents and open interest falling significantly. The USDA reported a private export sale of 264,000 metric tons for 2026/27 to unknown destinations. U.S. crop progress showed 92% of soybeans planted by June 7, ahead of normal pace, but condition ratings edged down. Export shipments fell 21.2% from the prior week and 28.8% year-on-year, with Egypt, China, and Mexico as top destinations. Chinese soybean imports declined 15.3% in May. Prices remain under pressure amid these mixed fundamental signals, with July soybeans near $11.15 per bushel.

Latest articles

Reddit Shares Pop After Wall Street Sees the Right Ad Signal

Reddit Shares Pop After Wall Street Sees the Right Ad Signal

9 June 2026
Reddit shares surged 6.6% to $182.44 after Cleveland Research and Piper Sandler cited stronger ad demand and raised revenue forecasts, with Cleveland noting 45% of advertisers beat ROI targets in Q2 and Reddit taking ad share from rivals, but risks remain around user growth, AI search traffic, and high valuation.
Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Go toTop